$GUER
Guerrilla RF, Inc. Stock $guer

$guer Overview Financials Valuation SEC Filings Company Website

2022 Q1 Form 10-Q Financial Statement

#000143774922012193 Filed on May 13, 2022

Income Statement

Concept	2022 Q1	2021 Q1
Revenue	$3.866M	$2.781M
YoY Change	39.01%
Cost Of Revenue	$1.547M	$1.093M
YoY Change	41.6%
Gross Profit	$2.319M	$1.688M
YoY Change	37.33%
Gross Profit Margin	59.98%	60.71%
Selling, General & Admin	$2.325M	$882.0K
YoY Change	163.67%
% of Gross Profit	100.3%	52.24%
Research & Development	$1.802M	$1.063M
YoY Change	69.5%
% of Gross Profit	77.72%	62.97%
Depreciation & Amortization	$250.9K	$79.42K
YoY Change	215.97%
% of Gross Profit	10.82%	4.7%
Operating Expenses	$4.127M	$1.945M
YoY Change	112.2%
Operating Profit	-$1.809M	-$256.7K
YoY Change	604.55%
Interest Expense	-$57.22K	-$148.8K
YoY Change	-61.55%
% of Operating Profit
Other Income/Expense, Net	-$57.22K	$387.0K
YoY Change	-114.79%
Pretax Income	-$1.866M	-$16.13K
YoY Change	11469.06%
Income Tax	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$1.866M	$130.2K
YoY Change	-1532.86%
Net Earnings / Revenue	-48.27%	4.68%
Basic Earnings Per Share	-$0.06	$0.02
Diluted Earnings Per Share	-$0.06	$0.01
COMMON SHARES
Basic Shares Outstanding	33.23M	6.703M
Diluted Shares Outstanding		10.07M

Balance Sheet

Concept	2022 Q1	2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$2.591M	$4.430K
YoY Change	58379.68%
Cash & Equivalents	$2.591M	$986.5K
Short-Term Investments
Other Short-Term Assets	$1.041M
YoY Change
Inventory	$1.639M
Prepaid Expenses	$1.041M
Receivables	$2.609M
Other Receivables	$0.00
Total Short-Term Assets	$7.880M	$4.430K
YoY Change	177779.71%
LONG-TERM ASSETS
Property, Plant & Equipment	$4.131M
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$4.407M	$0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets	$7.880M	$4.430K
Total Long-Term Assets	$4.407M	$0.00
Total Assets	$12.29M	$4.430K
YoY Change	277250.9%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.409M	$3.000K
YoY Change	46856.0%
Accrued Expenses	$116.1K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$35.00K
YoY Change	-100.0%
Long-Term Debt Due	$669.3K
YoY Change
Total Short-Term Liabilities	$2.201M	$38.00K
YoY Change	5693.22%
LONG-TERM LIABILITIES
Long-Term Debt	$2.837M	$0.00
YoY Change
Other Long-Term Liabilities	$160.6K
YoY Change
Total Long-Term Liabilities	$2.998M	$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$2.201M	$38.00K
Total Long-Term Liabilities	$2.998M	$0.00
Total Liabilities	$5.199M	$38.00K
YoY Change	13581.64%
SHAREHOLDERS EQUITY
Retained Earnings	-$16.90M
YoY Change
Common Stock	$3.323K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$7.088M	-$2.976M
YoY Change
Total Liabilities & Shareholders Equity	$12.29M	$4.430K
YoY Change	277250.9%

Cashflow Statement

Concept	2022 Q1	2021 Q1
OPERATING ACTIVITIES
Net Income	-$1.866M	$130.2K
YoY Change	-1532.86%
Depreciation, Depletion And Amortization	$250.9K	$79.42K
YoY Change	215.97%
Cash From Operating Activities	-$2.430M	-$648.6K
YoY Change	274.62%
INVESTING ACTIVITIES
Capital Expenditures	$152.5K	$11.00K
YoY Change	1286.04%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$152.5K	-$11.00K
YoY Change	1286.04%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$141.0K	$1.219M
YoY Change	-111.57%
NET CHANGE
Cash From Operating Activities	-$2.430M	-$648.6K
Cash From Investing Activities	-$152.5K	-$11.00K
Cash From Financing Activities	-$141.0K	$1.219M
Net Change In Cash	-$2.723M	$559.3K
YoY Change	-586.94%
FREE CASH FLOW
Cash From Operating Activities	-$2.430M	-$648.6K
Capital Expenditures	$152.5K	$11.00K
Free Cash Flow	-$2.582M	-$659.6K
YoY Change	291.48%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	33562635
CY2022Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000
CY2022Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2022Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2022Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000
CY2022Q1	us-gaap	Cash Cash	2600000	USD
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000
CY2022Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	33234894
CY2022Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	33234894
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	33222192
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	33222192
CY2022Q1	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	USD
CY2021Q1	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	USD
CY2021Q4	us-gaap	Deferred Offering Costs DeferredOfferingCosts	0	USD
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2022Q1	us-gaap	Finance Lease Liability FinanceLeaseLiability	2607618	USD
CY2022Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	304079	USD
CY2022Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	33257	USD
CY2021Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	31836	USD
CY2022Q1	guer	Finance Lease Cost FinanceLeaseCost	218663	USD
CY2021Q1	guer	Finance Lease Cost FinanceLeaseCost	20235	USD
CY2022Q1	us-gaap	Finance Lease Liability Payments Remainder Of Fiscal Year FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear	659740	USD
CY2022Q1	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	851233	USD
CY2022Q1	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	830311	USD
CY2022Q1	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	817920	USD
CY2022Q1	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	753840	USD
CY2022Q1	guer	Finance Lease Liability To Be Paid After Year Four FinanceLeaseLiabilityToBePaidAfterYearFour	20585	USD
CY2022Q1	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	3933629	USD
CY2022Q1	guer	Finance Lease Liability Undiscounted Excess Amount Remainder Of Fiscal Year FinanceLeaseLiabilityUndiscountedExcessAmountRemainderOfFiscalYear	162340	USD
CY2022Q1	guer	Finance Lease Liability Undiscounted Excess Amount Next Twelve Months FinanceLeaseLiabilityUndiscountedExcessAmountNextTwelveMonths	171400	USD
CY2022Q1	guer	Finance Lease Liability Undiscounted Excess Amount Year Two FinanceLeaseLiabilityUndiscountedExcessAmountYearTwo	127959	USD
CY2022Q1	guer	Finance Lease Liability Undiscounted Excess Amount Year Three FinanceLeaseLiabilityUndiscountedExcessAmountYearThree	79063	USD
CY2022Q1	guer	Finance Lease Liability Undiscounted Excess Amount Year Four FinanceLeaseLiabilityUndiscountedExcessAmountYearFour	29009	USD
CY2022Q1	guer	Finance Lease Liability Undiscounted Excess Amount After Year Four FinanceLeaseLiabilityUndiscountedExcessAmountAfterYearFour	180	USD
CY2022Q1	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	569951	USD
CY2022Q1	guer	Finance Lease Liability Remainder Of Fiscal Year FinanceLeaseLiabilityRemainderOfFiscalYear	497400	USD
CY2022Q1	guer	Finance Lease Liability Year One FinanceLeaseLiabilityYearOne	679833	USD
CY2022Q1	guer	Finance Lease Liability Year Two FinanceLeaseLiabilityYearTwo	702352	USD
CY2022Q1	guer	Finance Lease Liability Year Three FinanceLeaseLiabilityYearThree	738857	USD
CY2022Q1	guer	Finance Lease Liability Year Four FinanceLeaseLiabilityYearFour	724831	USD
CY2022Q1	guer	Finance Lease Liability After Year Four FinanceLeaseLiabilityAfterYearFour	20405	USD
CY2022Q1	us-gaap	Finance Lease Liability FinanceLeaseLiability	3363678	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	98718	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	133814	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	67569	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	300101	USD
CY2022Q1	guer	Operating Lease Liability Remainder Of Fiscal Year OperatingLeaseLiabilityRemainderOfFiscalYear	86168	USD
CY2022Q1	guer	Operating Lease Liability Year One OperatingLeaseLiabilityYearOne	124389	USD
CY2022Q1	guer	Operating Lease Liability Year Two OperatingLeaseLiabilityYearTwo	66211	USD
CY2022Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	276768	USD
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2021Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2021Q1	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2022Q1	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction	0	USD
CY2022Q1	us-gaap	Cash Cash	2590646	USD
CY2021Q4	us-gaap	Cash Cash	5313985	USD
CY2022Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2609055	USD
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1667006	USD
CY2022Q1	us-gaap	Inventory Net InventoryNet	1639042	USD
CY2021Q4	us-gaap	Inventory Net InventoryNet	1439014	USD
CY2022Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	1041328	USD
CY2021Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	1187418	USD
CY2022Q1	us-gaap	Assets Current AssetsCurrent	7880071	USD
CY2021Q4	us-gaap	Assets Current AssetsCurrent	9607423	USD
CY2022Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	275984	USD
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	0	USD
CY2022Q1	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	4130590	USD
CY2021Q4	us-gaap	Assets Assets	10634735	USD
CY2022Q1	guer	Shortterm Debt And Longterm Debt Current Maturities ShorttermDebtAndLongtermDebtCurrentMaturities	7310	USD
CY2021Q4	guer	Shortterm Debt And Longterm Debt Current Maturities ShorttermDebtAndLongtermDebtCurrentMaturities	5117	USD
CY2022Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	116128	USD
CY2021Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1063106	USD
CY2021Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	1027312	USD
CY2022Q1	us-gaap	Assets Assets	12286645	USD
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	0	USD
CY2022Q1	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	669309	USD
CY2022Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1085843	USD
CY2021Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	118420	USD
CY2022Q1	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1408676	USD
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1186443	USD
CY2022Q1	us-gaap	Liabilities Current LiabilitiesCurrent	2201423	USD
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1309980	USD
CY2022Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	160640	USD
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	0	USD
CY2022Q1	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	2694369	USD
CY2021Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	264347	USD
CY2022Q1	us-gaap	Long Term Notes Payable LongTermNotesPayable	142590	USD
CY2021Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	144783	USD
CY2022Q1	us-gaap	Liabilities Liabilities	5199022	USD
CY2021Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	576650	USD
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1239650	USD
CY2021Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	305314	USD
CY2021Q4	us-gaap	Liabilities Liabilities	1719110	USD
CY2022Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2022Q1	us-gaap	Common Stock Value CommonStockValue	3323	USD
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	3322	USD
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	4127499	USD
CY2021Q1	us-gaap	Operating Expenses OperatingExpenses	1945070	USD
CY2022Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	23996792	USD
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	23958705	USD
CY2022Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-16912492	USD
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-15046402	USD
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	7087623	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	8915625	USD
CY2022Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	12286645	USD
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	10634735	USD
CY2022Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	3865911	USD
CY2021Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	2781022	USD
CY2022Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1547281	USD
CY2021Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1092692	USD
CY2022Q1	us-gaap	Gross Profit GrossProfit	2318630	USD
CY2021Q1	us-gaap	Gross Profit GrossProfit	1688330	USD
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-1808869	USD
CY2021Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-256740	USD
CY2022Q1	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-57221	USD
CY2021Q1	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-148825	USD
CY2022Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	0	USD
CY2021Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	535800	USD
CY2022Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-57221	USD
CY2021Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	386975	USD
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-1866090	USD
CY2022Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1802006	USD
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.06
CY2021Q1	us-gaap	Share Based Compensation ShareBasedCompensation	6352	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	130235	USD
CY2022Q1	guer	Amortization Of Warrants AmortizationOfWarrants	0	USD
CY2021Q1	guer	Amortization Of Warrants AmortizationOfWarrants	6208	USD
CY2022Q1	guer	Gain Loss On Ppp Loan Forgiveness GainLossOnPPPLoanForgiveness	-0	USD
CY2021Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.02
CY2021Q1	guer	Gain Loss On Ppp Loan Forgiveness GainLossOnPPPLoanForgiveness	535800	USD
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	942049	USD
CY2021Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	107678	USD
CY2022Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	200028	USD
CY2021Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-95511	USD
CY2022Q1	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-146090	USD
CY2022Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	3127940	USD
CY2021Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	0	USD
CY2022Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	73810	USD
CY2021Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	11000	USD
CY2021Q1	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	129567	USD
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	148423	USD
CY2021Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-193307	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2429861	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-648627	USD
CY2022Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	152464	USD
CY2021Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	11000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	986540	USD
CY2022Q1	us-gaap	Nature Of Operations NatureOfOperations	<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><b/></p><p style="margin: 0pt;"/> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b><em style="font: inherit;">1.</em> ORGANIZATION AND NATURE OF BUSINESS</b></p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Guerrilla RF, Inc. (formerly known as Laffin Acquisition Corp., the “Company”) was incorporated in the State of Delaware on <em style="font: inherit;"> November 9, 2020. </em>On <em style="font: inherit;"> October </em><em style="font: inherit;">22,</em> <em style="font: inherit;">2021,</em> the Company's wholly-owned subsidiary, Guerrilla RF Acquisition Corp., a corporation formed in the State of Delaware on <em style="font: inherit;"> October </em><em style="font: inherit;">20,</em> <em style="font: inherit;">2021</em> (“Acquisition Sub”) and privately held Guerrilla RF Operating Corporation (formerly known as Guerrilla RF, Inc.) entered into an Agreement and Plan of Merger and Reorganization (the “Merger Agreement”). Pursuant to the terms of the Merger Agreement, on <em style="font: inherit;"> October </em><em style="font: inherit;">22,</em> <em style="font: inherit;">2021</em> (the “Closing Date”), Acquisition Sub merged with and into Guerrilla RF Operating Corporation with Guerrilla RF Operating Corporation continuing as the surviving corporation and a wholly-owned subsidiary of the Company (the “Merger”). </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Prior to the Merger, Laffin Acquisition Corp. was a “shell” company registered under the Securities Exchange Act of <em style="font: inherit;">1934,</em> as amended (the "Exchange Act"), with <em style="font: inherit;">no</em> specific business plan or purpose until it began operating the business of Guerrilla RF Operating Corporation following the closing of the Merger.</p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">All references in this Quarterly Report to “Guerrilla RF” refer to Guerrilla RF Operating Corporation, our direct, wholly-owned subsidiary. Unless otherwise stated or the context otherwise indicates, references to the “Company”, “we”, “our”, “us” or similar terms refer to Guerrilla RF, Inc. (formerly known as Laffin Acquisition Corp.) together with its wholly-owned subsidiary, Guerrilla RF. Guerrilla RF holds all material assets and conducts all business activities and operations of the Company. Accordingly, there are frequent references to Guerrilla RF throughout this Quarterly Report.</p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Guerrilla RF designs and manufactures high‐performance Monolithic Microwave Integrated Circuits (MMICs) for the wireless infrastructure market. Guerrilla RF primarily focuses on researching and developing its existing and future products and building an infrastructure to handle a global distribution network; therefore, it has incurred significant start‐up losses. </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">The Merger was accounted for as a “reverse acquisition” since, immediately following the consummation of the Merger, Guerrilla RF effectively controlled the Company. For accounting purposes, Guerrilla RF was deemed the accounting acquirer in the Merger. Consequently, the Merger is treated as a recapitalization of Guerrilla RF (i.e., a capital transaction involving the issuance of shares by the Company for the shares of Guerrilla RF). Accordingly, the assets, liabilities, and results of operations of Guerrilla RF became the historical consolidated financial statements of the Company, and the Company’s assets, liabilities, and results of operations were consolidated with Guerrilla RF beginning at the Closing Date. <em style="font: inherit;">No</em> step-up in basis or intangible assets or goodwill were recorded in the Merger.</p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt -1pt; text-indent: 0pt; text-align: justify;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt -1pt; text-indent: 0pt; text-align: justify;"><b>Liquidity and Going Concern</b></p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt -1pt; text-indent: 0pt; text-align: justify;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">In accordance with Financial Accounting Standards (“FASB”) Accounting Standards Update (“ASU”) <em style="font: inherit;">No.</em> <em style="font: inherit;">2014</em>-<em style="font: inherit;">15,</em> <i>Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern (Subtopic <em style="font: inherit;">205</em>-<em style="font: inherit;">40</em>)</i>, the Company has evaluated whether there are conditions and events, considered in the aggregate, that raise substantial doubt about the Company’s ability to continue as a going concern within <em style="font: inherit;">one</em> year after the date that the unaudited interim condensed consolidated financial statements are issued. The accompanying unaudited interim condensed consolidated financial statements have been presented on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the ordinary course of business. The Company has historically financed its activities principally from common and preferred equity securities and debt issuances.</p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><span style="background-color:#ffffff;">The Company has incurred recurring losses, and negative cash flows from operations in nearly every fiscal period since its inception, including a net loss of $1.9 million for the <em style="font: inherit;">three</em> months ended <em style="font: inherit;"> March 31, 2022</em></span>. In addition, as of <em style="font: inherit;"> March 31, 2022, </em>the Company had an accumulated deficit o<span style="background-color:#ffffff;">f $16.9 million.</span> The Company expects losses and negative cash flows to continue, primarily as a result of continued sales and marketing efforts and planned investment in research and development. The Company had a cash balance of $2.6 million at <em style="font: inherit;"> March 31, 2022. </em>The Company believes its cash, together with its access to other funding, including unused availability of $2.0 million under its factoring arrangement (further described in Note <em style="font: inherit;">5</em>), will provide sufficient resources to support operations into the <em style="font: inherit;">fourth</em> quarter of <em style="font: inherit;">2022.</em> The Company anticipates it will need additional funds to promote new products and working capital necessary to support increased sales, and it is actively evaluating alternative funding sources as part of its ongoing strategic planning. </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">If the Company is unable to obtain additional financing in sufficient amounts or on acceptable terms, the Company will be forced to delay, reduce, or eliminate some or all of its research and development programs and product portfolio expansion, which could adversely affect its operating results or business prospects. Although management continues to pursue these plans, there is <em style="font: inherit;">no</em> assurance that the Company will be successful in obtaining sufficient funding on terms acceptable to the Company to fund continuing operations, if at all. The precise amount and timing of the funding needs cannot be determined accurately at this time. They will depend on many factors, including the market demand for the Company's products, the quality of product development efforts, management of working capital, and the continuation of standard payment terms and conditions for purchasing goods and services. This requirement for additional funding raises substantial doubt about our ability to continue as a going concern. The unaudited interim condensed consolidated financial statements do <em style="font: inherit;">not</em> include any adjustments relating to the recoverability of the recorded assets or the classification of liabilities that <em style="font: inherit;"> may </em>be necessary should the Company be unable to continue as a going concern.</p> <p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left"/> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>Risks and Uncertainties</b></p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">The Company is subject to several risks associated with companies at a similar stage, including dependence on key individuals, competition from similar products and larger companies, volatility of the industry, ability to obtain adequate financing to support growth, the ability to attract and retain additional qualified personnel to manage the anticipated growth of the Company, and general economic conditions.</p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt -1pt; text-align: justify;">In <em style="font: inherit;"> December 2019, </em>a novel strain of coronavirus disease (“COVID-<em style="font: inherit;">19”</em>) was reported, and in <em style="font: inherit;"> March 2020, </em>the World Health Organization characterized COVID-<em style="font: inherit;">19</em> as a global pandemic. The COVID-<em style="font: inherit;">19</em> pandemic has forced international, federal, state, and local governments to enforce prohibitions of non-essential activities. The Company <em style="font: inherit;">first</em> saw the impact of COVID-<em style="font: inherit;">19</em> in the <em style="font: inherit;">first</em> quarter of <em style="font: inherit;">2020.</em> The extent and duration of the adverse impact of COVID-<em style="font: inherit;">19</em> on the Company over the longer term remains uncertain and dependent on future developments that cannot be accurately predicted at this time, such as the severity and transmission rate of COVID-<em style="font: inherit;">19</em> and its related variants, the extent and effectiveness of containment actions taken, including mobility restrictions, the timing, availability, and effectiveness of vaccines, and the impact of these and other factors on travel behavior in general and on the Company’s business.</p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt -1pt; text-align: justify;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt -1pt; text-align: justify;">As the impact of COVID-<em style="font: inherit;">19</em> continues to evolve, estimates and assumptions about future events and their effects cannot be determined with certainty and therefore require increased judgment. These estimates and assumptions <em style="font: inherit;"> may </em>change in future periods and will be recognized in the condensed consolidated financial statements as new events occur, and additional information becomes known. To the extent the Company’s actual results differ materially from those estimates and assumptions, the Company’s future condensed consolidated financial statements could be affected.</p>
CY2022Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	250937	USD
CY2021Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	79419	USD
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	32856	USD
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.06
CY2021Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.01
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	8915625	USD
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-1866090	USD
CY2022Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	5232	USD
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	32856	USD
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	7087623	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-3125294	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	130235	USD
CY2021Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	12667	USD
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	6352	USD
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	-2976040	USD
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-1866090	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	130235	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-152464	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-11000	USD
CY2022Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	5232	USD
CY2021Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	12667	USD
CY2022Q1	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	0	USD
CY2021Q1	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	1236865	USD
CY2022Q1	us-gaap	Proceeds From Issuance Of Unsecured Debt ProceedsFromIssuanceOfUnsecuredDebt	0	USD
CY2021Q1	us-gaap	Proceeds From Issuance Of Unsecured Debt ProceedsFromIssuanceOfUnsecuredDebt	833300	USD
CY2022Q1	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	-0	USD
CY2021Q1	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	850000	USD
CY2022Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	146246	USD
CY2021Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	13934	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-141014	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1218898	USD
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-2723339	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	559271	USD
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	5313985	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	427269	USD
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	2590646	USD
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-1900000	USD
CY2022Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-16900000	USD
CY2021Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	482972	USD
CY2022Q1	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"/> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>Use of Estimates</b></p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">The preparation of the unaudited interim condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the unaudited interim condensed consolidated financial statements, and reported amounts of revenue and expenses during the reporting period. The Company’s significant estimates and judgments involve the identification of performance obligations in revenue recognition and the valuation of share-based compensation, including the underlying fair value of the common stock. Accordingly, actual results could differ from those estimates.</p> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;"> </p>
CY2022Q1	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"/> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>Concentrations of Credit Risk and Major Customers</b></p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Financial instruments at <em style="font: inherit;"> March 31, 2022 </em>and <em style="font: inherit;">2021</em> that potentially subject the Company to concentration of credit risk consist primarily of cash and accounts receivable.</p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">The Company’s cash is deposited with major financial institutions in the U.S. At times, deposits in financial institutions located in the U.S. <em style="font: inherit;"> may </em>be in excess of the amount of insurance provided on such deposits by the Federal Deposit Insurance Corporation (FDIC). To date, the Company has <em style="font: inherit;">not</em> experienced any losses on its cash deposits.</p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">The Company’s accounts receivable are derived from revenue earned from customers located in and outside of the U.S. Major customers are defined as those generating revenue in excess of <em style="font: inherit;">10%</em> of the Company’s aggregate annual revenue. The Company had <span style="background-color:#ffffff;">one </span>major distributor customer, Richardson RFPD, Inc., during the <em style="font: inherit;">three</em> months <span style="background-color:#ffffff;">ended <em style="font: inherit;"> March 31, 2022 </em>and <em style="font: inherit;">2021</em> accounting for 85% and 80% of product shipment revenue for the <em style="font: inherit;">three</em> months ended <em style="font: inherit;"> March 31, 2022 </em>and <em style="font: inherit;">2021,</em> respectively. Accounts receivable from our major distributor customer represented 80% of accounts receivable at <em style="font: inherit;"> March 31, 2022 </em>and <em style="font: inherit;">2021.</em> </span></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p>
CY2022Q1	guer	Factoring Agreement Advance Amount Percentage Of Accounts Receivable FactoringAgreementAdvanceAmountPercentageOfAccountsReceivable	0.85	pure
CY2022Q1	guer	Factoring Agreement Receivables Term Oustanding FactoringAgreementReceivablesTermOustanding	P90D
CY2022Q1	guer	Factoring Agreement Percentage Of Receivables Collateral FactoringAgreementPercentageOfReceivablesCollateral	0.15	pure
CY2022Q1	us-gaap	Transfer Of Financial Assets Accounted For As Sales Fair Value Of Derecognized Assets TransferOfFinancialAssetsAccountedForAsSalesFairValueOfDerecognizedAssets	0	USD
CY2021Q1	us-gaap	Transfer Of Financial Assets Accounted For As Sales Fair Value Of Derecognized Assets TransferOfFinancialAssetsAccountedForAsSalesFairValueOfDerecognizedAssets	1455135	USD
CY2022Q1	us-gaap	Securitized Assets And Any Other Financial Assets Managed Together Principal Amount Outstanding SecuritizedAssetsAndAnyOtherFinancialAssetsManagedTogetherPrincipalAmountOutstanding	0	USD
CY2021Q1	us-gaap	Securitized Assets And Any Other Financial Assets Managed Together Principal Amount Outstanding SecuritizedAssetsAndAnyOtherFinancialAssetsManagedTogetherPrincipalAmountOutstanding	218270	USD
CY2022Q1	us-gaap	Deferred Offering Costs DeferredOfferingCosts	0	USD
CY2021Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	339746	USD
CY2022Q1	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	674735	USD
CY2022Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	8772	USD
CY2022Q1	us-gaap	Advertising Expense AdvertisingExpense	7750	USD
CY2021Q1	us-gaap	Advertising Expense AdvertisingExpense	5402	USD
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	33228202
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6702686
CY2021Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	10069021
CY2022Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	3629760
CY2022Q1	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	656525	USD
CY2021Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	629090	USD
CY2022Q1	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	317494	USD
CY2022Q1	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	9712	USD
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1027312	USD
CY2022Q1	us-gaap	Depreciation Depreciation	300000	USD
CY2022Q1	us-gaap	Cash Flows Between Transferee And Transferor Servicing Fees CashFlowsBetweenTransfereeAndTransferorServicingFees	0	USD
CY2021	us-gaap	Cash Flows Between Transferee And Transferor Servicing Fees CashFlowsBetweenTransfereeAndTransferorServicingFees	87122	USD
CY2021Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	12794	USD
CY2022Q1	us-gaap	Inventory Net InventoryNet	1639042	USD
CY2021Q4	us-gaap	Inventory Net InventoryNet	1439014	USD
CY2022Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	5960016	USD
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	2605800	USD
CY2022Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1829426	USD
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1578488	USD
CY2022Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4130590	USD
CY2021Q1	us-gaap	Depreciation Depreciation	100000	USD
CY2021	us-gaap	Depreciation Depreciation	400000	USD
CY2022Q1	guer	Factoring Agreement Advance Amount Percentage Of Accounts Receivable FactoringAgreementAdvanceAmountPercentageOfAccountsReceivable	0.85	pure
CY2022Q1	guer	Factoring Agreement Factoring Fee First Thirty Days Percentage Of Invoice Face Value FactoringAgreementFactoringFeeFirstThirtyDaysPercentageOfInvoiceFaceValue	0.0098	pure
CY2022Q1	guer	Factoring Agreement Factoring Fee After Thirty Days Percentage Of Invoice Face Value FactoringAgreementFactoringFeeAfterThirtyDaysPercentageOfInvoiceFaceValue	0.000327	pure
CY2022Q1	guer	Factoring Agreement Minimum Invoice Fee FactoringAgreementMinimumInvoiceFee	1.50	USD
CY2022Q1	us-gaap	Short Term Borrowings ShortTermBorrowings	0	USD
CY2022Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	5117	USD
CY2022Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	8772	USD
CY2022Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	8772	USD
CY2021Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	6400	USD
CY2022Q1	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	0	USD
CY2022Q1	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	0	USD
CY2022Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	8772	USD
CY2022Q1	guer	Longterm Debt Maturity After Year Four LongtermDebtMaturityAfterYearFour	109695	USD
CY2022Q1	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	149900	USD
CY2022Q1	guer	Common Stock Voting Rights Vote Per Share CommonStockVotingRightsVotePerShare	1	pure
CY2022Q1	us-gaap	Dividends Common Stock DividendsCommonStock	0	USD
CY2014Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	568000
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	1260000
CY2022Q1	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit	0.70
CY2022Q1	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit	1.57
CY2022Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	32900	USD
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2022Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y3M
CY2021Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.67	pure
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.45	pure
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0011	pure
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0030	pure
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	1.21
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0.53
CY2022Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	816298	USD
CY2021Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	21691	USD
CY2022Q1	guer	Sharebased Payment Arrangement Granted Award Cost Not Yet Recognized Period For Recognition SharebasedPaymentArrangementGrantedAwardCostNotYetRecognizedPeriodForRecognition	P1Y7M6D
CY2022Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	12702
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	20000	USD
CY2022Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	4500000	USD
CY2022Q1	guer	Sharebased Payment Arrangement Granted Award Option Cost Not Yet Recognized Amount SharebasedPaymentArrangementGrantedAwardOptionCostNotYetRecognizedAmount	500000	USD
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3180882
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.38
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y3M18D
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	130000
CY2022Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	2.00
CY2022Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	12702
CY2022Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.41
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3298180
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.44
CY2022Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y5M19D
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	2690983
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	0.34
CY2022Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P4Y9M29D
CY2021Q4	guer	Factor Of Change In Exercise Price Of Options FactorOfChangeInExercisePriceOfOptions	2.95	pure
CY2022Q1	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	2607618	USD
CY2022Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	304079	USD
CY2022Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	275984	USD
CY2022Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	116128	USD
CY2022Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	160640	USD
CY2022Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	276768	USD
CY2022Q1	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	2964182	USD
CY2022Q1	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	669309	USD
CY2022Q1	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	2694369	USD
CY2022Q1	us-gaap	Finance Lease Liability FinanceLeaseLiability	3363678	USD
CY2022Q1	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	163758	USD
CY2021Q1	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	16446	USD
CY2022Q1	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	54905	USD
CY2021Q1	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	3789	USD
CY2022Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y3M
CY2022Q1	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P4Y7M17D
CY2022Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0700	pure
CY2022Q1	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.0693	pure
CY2022Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	32473	USD
CY2022Q1	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	54070	USD
CY2022Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	146246	USD
CY2022Q1	guer	Lessee Operating Lease Liability Undiscounted Excess Amount Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityUndiscountedExcessAmountRemainderOfFiscalYear	12550	USD
CY2022Q1	guer	Lessee Operating Lease Liability Undiscounted Excess Amount Year One LesseeOperatingLeaseLiabilityUndiscountedExcessAmountYearOne	9425	USD
CY2022Q1	guer	Lessee Operating Lease Liability Undiscounted Excess Amount Year Two LesseeOperatingLeaseLiabilityUndiscountedExcessAmountYearTwo	1358	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	23333	USD
CY2022Q1	guer	Lessee Operating Lease Lease Not Yet Commenced Building Asset Additions LesseeOperatingLeaseLeaseNotYetCommencedBuildingAssetAdditions	4000000.0	USD
CY2022Q1	guer	Lessee Operating Lease Lease Not Yet Commenced Annual Lease Expense LesseeOperatingLeaseLeaseNotYetCommencedAnnualLeaseExpense	1100000	USD
CY2022Q1	guer	Severance Pay Obligation Percentage SeverancePayObligationPercentage	1	pure
CY2022Q1	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction	120000	USD
CY2022Q1	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	2588000	USD
CY2022Q1	us-gaap	Defined Contribution Plan Employer Matching Contribution Percent DefinedContributionPlanEmployerMatchingContributionPercent	0.04	pure
CY2022Q1	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	79234	USD
CY2021Q1	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	41115	USD

Files In Submission

Name	View Source	Status
0001437749-22-012193-index-headers.html	Edgar Link	pending
0001437749-22-012193-index.html	Edgar Link	pending
0001437749-22-012193.txt	Edgar Link	pending
0001437749-22-012193-xbrl.zip	Edgar Link	pending
ex_355256.htm	Edgar Link	pending
ex_355257.htm	Edgar Link	pending
ex_355258.htm	Edgar Link	pending
ex_355259.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
guer-20220331.xsd	Edgar Link	pending
guer-20220331_cal.xml	Edgar Link	unprocessable
guer-20220331_def.xml	Edgar Link	unprocessable
guer-20220331_lab.xml	Edgar Link	unprocessable
guer-20220331_pre.xml	Edgar Link	unprocessable
guer20220331b_10q.htm	Edgar Link	pending
guer20220331b_10q_htm.xml	Edgar Link	completed
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$GUER
Guerrilla RF, Inc. Stock $guer

2022 Q1 Form 10-Q Financial Statement

#000143774922012193 Filed on May 13, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$GUER Guerrilla RF, Inc. Stock $guer

2022 Q1 Form 10-Q Financial Statement

#000143774922012193 Filed on May 13, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$GUER
Guerrilla RF, Inc. Stock $guer